Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-18 to 2023-06-09
Current total value of award: $669.26
Description: 4561029037!ZOLADEX 3.6 MG IMPLANT SYRNS